Clinical Trial

A Study of YL242 in Subjects With Advanced Solid Tumors

Name: A Study of YL242 in Subjects With Advanced Solid Tumors — clinical trial record (NCT07197827)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label study to evaluate the safety and tolerability of YL242 monotherapy and combination in participants with advanced solid malignant tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-26.

Trial Details

NCT Number	NCT07197827
Lead Sponsor	MediLink Therapeutics (Suzhou) Co., Ltd.
Conditions	Advanced Solid Tumor
Enrollment	424 participants
Start Date	2025-09-22
Primary Completion	2028-09 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2025-12-24